Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12611000316909Phase 4Not yet recruiting
Phase 4 trial of pantoprazole, sponsored by Department of Health. Primary endpoint: Dose-normalized mycophenolic acid and MPA-glucuronide area under the curve. Planned start Jun 2011; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12611000316909.